Morpholine,4-(1-pentenyl)-,(E)- (9CI)

Suppliers

Names

[ CAS No. ]:
132553-33-4

[ Name ]:
Morpholine,4-(1-pentenyl)-,(E)- (9CI)

[Synonym ]:
4-[(1E)-1-Penten-1-yl]morpholine
MFCD00457261
Morpholine, 4-[(1E)-1-penten-1-yl]-

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
235.0±29.0 °C at 760 mmHg

[ Molecular Formula ]:
C9H17NO

[ Molecular Weight ]:
155.237

[ Flash Point ]:
68.2±26.6 °C

[ Exact Mass ]:
155.131012

[ LogP ]:
2.43

[ Vapour Pressure ]:
0.1±0.5 mmHg at 25°C

[ Index of Refraction ]:
1.530


Related Compounds

  • Morpholine,4-(1-pentenyl)- (9CI)
  • Isoxazole, 3,5-dimethyl-4-(1-pentenyl)-, (E)- (9CI)
  • Benzene, 1-ethoxy-2-methoxy-4-(1-pentenyl)-, (E)- (9CI)
  • Pyridine, 4-(1-pentenyl)- (9CI)
  • 1,3-Dioxolan-2-one,4-(1-pentenyl)- (9CI)
  • Pyrazine, 2,5-dimethyl-3-(1-pentenyl)-, (E)- (9CI)
  • N-methyl-1-[3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-N-[(pyridin-4-yl)methyl]azetidin-3-amine
  • 6-[Methyl({1-[3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]azetidin-3-yl})amino]pyridine-3-carbonitrile
  • 5-chloro-N-methyl-N-{1-[3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]azetidin-3-yl}pyridin-2-amine
  • 4-[(3-{[(2-Methylpyridin-4-yl)oxy]methyl}piperidin-1-yl)sulfonyl]-2,1,3-benzothiadiazole
  • 1-{1-[6-(cyclopentyloxy)pyridine-3-carbonyl]azetidin-3-yl}-2-cyclopropyl-1H-1,3-benzodiazole
  • 1-[3-(3-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-N-methyl-N-[(2-methyl-1,3-oxazol-4-yl)methyl]azetidin-3-amine
  • 4-({1-[(1,2-dimethyl-1H-imidazol-4-yl)sulfonyl]piperidin-4-yl}methoxy)-6-phenylpyrimidine
  • 4-{[Methyl({1-[3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]azetidin-3-yl})amino]methyl}benzonitrile
  • 2-methyl-1-[(9-methyl-9H-purin-6-yl)amino]-3-(thiophen-3-yl)propan-2-ol
  • 5-Fluoro-4-[4-({imidazo[1,2-a]pyridin-2-yl}methyl)piperazin-1-yl]-6-phenylpyrimidine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.